|4500 Main St. , Kansas City, MO 64111|
|Fund Manager||Team Managed|
The fund seeks long-term capital growth. Income is a secondary objective. Under normal market conditions, the portfolio managers will invest at least 80% of the fund s net assets in medium size companies. The portfolio managers consider medium size companies to include those whose market capitalizations at the time of purchase are within the capitalization range of the Russell 3000 Index, excluding the largest 100 such companies. The portfolio managers intend to manage the fund so that its weighted capitalization falls within the capitalization range of the members of the Russell Midcap Index. Though market capitalization may change from time to time, as of June 30, 2020, the capitalization ranges of the Russell 3000 Index, excluding the largest 100 companies, and the Russell Midcap Index were $41.0 million to $60.3 billion and $557.0 million to $48.0 billion, respectively. In selecting stocks for the fund, the portfolio managers look for companies whose stock price may not reflect the company s value. The managers attempt to purchase the stocks of these undervalued companies and hold each stock until the price has increased to, or is higher than, a level the managers believe more accurately reflects the fair value of the company. The fund may invest a portion of its assets in foreign securities when these securities meet the portfolio managers standards of selection. The portfolio managers may sell stocks from the fund s portfolio if they believe a stock no longer meets their valuation criteria, a stock s risk parameters outweigh its return opportunity, more attractive alternatives are identified or specific events alter a stock s prospects.
|Asset Type||% Of Allocation|
|Total Net Assets||1.80 B|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$0|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 06/30/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 06/30/2021|
|Life Of Fund||
|Symbol||Company Name||% Of Assets|
|ZBH||ZIMMER BIOMET HOLDINGS INC||3.02%|
|BK||BANK OF NEW YORK MELLON CORP||2.54%|
|NTRS||NORTHERN TRUST CORP||2.19%|
|EMR||EMERSON ELECTRIC CO||2.10%|
|AAP||ADVANCE AUTO PARTS||1.98%|
|CAG||CONAGRA BRANDS INC||1.93%|
|DGX||QUEST DIAGNOSTICS INC||1.90%|
|UHS||UNIVERSAL HEALTH SERVICES INC||1.89%|
Join the Action Alerts PLUS Community today!
Micron topped analysts' fourth quarter expectations but provided tepid outlook for the first quarter.
Wolfe Research upgraded Chewy to outperform, saying a drop in net new customer additions should reverse in fiscal 2022.
Ahead of third-quarter earnings season, James 'Rev Shark' Deporre has some thoughts on what investors should be thinking about.
Gogo, Huntsman, Thor Industries, United Natural Foods and Sonoma Pharmaceuticals are five top stock gainers for Tuesday.
Stocks end sharply lower Tuesday as Wall Street contends with rolling blackouts in China, record high energy prices in Europe and gas line-ups in Britain.
Aurora Cannabis had a tough quarter, but Cowen analysts still expect strong growth margins in 2022.